Influence of chrysin on hepatic marker enzymes and lipid profile against D-galactosamine-induced hepatotoxicity rats

被引:49
作者
Pushpavalli, Ganesan [1 ]
Veeramani, Chinnadurai [1 ]
Pugalendi, Kodukkur Viswanathan [1 ]
机构
[1] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India
关键词
Chrysin; D-Galactosamine; Hepatic marker enzymes; Kidney function markers; Lipid profile; LIVER-FAILURE; FLAVONOIDS; CHOLESTEROL; LIPOPROTEIN; INHIBITION; MECHANISM; CARBON; ALPHA;
D O I
10.1016/j.fct.2010.03.040
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Chrysin is a flavonoid that exists in nature and is the major component of some traditional medicinal herbs. We investigated the hepatoprotective and antihyperlipidaemic potential of chrysin against D-galactosamine (a single intraperitoneal injection 400 mg/kg BW) induced hepatotoxicity in male albino Wistar rats. D-GalN rats exhibited an increased hepato and nephro toxicity marker activities aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and gamma glutamyl transpeptidase and total bilirubin level while urea, uric acid and creatinine and lipid profile. It also negatively affected the serum total protein, albumin and A/G ratio. Rats treated with chrysin at different concentrations (25, 50 and 100 mg/kg BW) caused a significant improvement in serum protein level, decreased hepato and nephro toxicity markers. It also decreased the levels of very low density lipoprotein cholesterol and low density lipoprotein cholesterol while high density lipoprotein cholesterol significantly increased. It also decreased the levels of total cholesterol, phospholipids, triglycerides, free fatty acids in the plasma and tissues of liver and kidney. The effect of chrysin (25 mg/kg) is comparable with silymarin, a known hepatoprotective drug. Chrysin thus exhibits hepatoprotective and antihyperlipidaemic activity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1654 / 1659
页数:6
相关论文
共 48 条
[21]   STUDIES ON MECHANISM OF GALACTOSAMINE HEPATITIS - ACCUMULATION OF GALACTOSAMINE-1-PHOSPHATE AND ITS INHIBITION OF UDP-GLUCOSE PYROPHOSPHORYLASE [J].
KEPPLER, D ;
DECKER, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1969, 10 (02) :219-+
[22]   EXPERIMENTAL HEPATITIS INDUCED BY D-GALACTOSAMINE [J].
KEPPLER, D ;
LESCH, R ;
REUTTER, W ;
DECKER, K .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1968, 9 (02) :279-&
[23]   TRAPPING OF URIDINE PHOSPHATES BY D-GALACTOSAMINE, D-GLUCOSAMINE, AND 2-DEOXY-D-GALACTOSE - A STUDY ON MECHANISM OF GALACTOSAMINE HEPATITIS [J].
KEPPLER, DOR ;
RUDIGIER, JF ;
BISCHOFF, E ;
DECKER, KFA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1970, 17 (02) :246-+
[24]   ESTIMATION OF PLASMA PHOSPHATASE BY DETERMINATION OF HYDROLYSED PHENOL WITH AMINO-ANTIPYRINE [J].
KIND, PRN ;
KING, EJ .
JOURNAL OF CLINICAL PATHOLOGY, 1954, 7 (04) :322-326
[25]   HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND PREMATURE CORONARY HEART-DISEASE IN URBAN JAPANESE MEN [J].
KITAMURA, A ;
ISO, H ;
NAITO, Y ;
IIDA, M ;
KONISHI, M ;
FOLSOM, AR ;
SATO, S ;
KIYAMA, M ;
NAKAMURA, M ;
SANKAI, T ;
SHIMAMOTO, T ;
KOMACHI, Y .
CIRCULATION, 1994, 89 (06) :2533-2539
[26]   Antioxidant and prooxidant effects of phenolics on pancreatic β-cells in vitro [J].
Lapidot, TM ;
Walker, MD ;
Kanner, J .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2002, 50 (25) :7220-7225
[27]   Effects of acetylbergenin against D-galactosamine-induced hepatotoxicity in rats [J].
Lim, HK ;
Kim, HS ;
Choi, HS ;
Oh, S ;
Jang, CG ;
Choi, J ;
Kim, SH ;
Chang, MJ .
PHARMACOLOGICAL RESEARCH, 2000, 42 (05) :471-474
[28]   Preventive effects of flavonoids on alloxan-induced diabetes mellitus in rats [J].
Lukacinova, A. ;
Mojzis, J. ;
Benacka, R. ;
Keller, J. ;
Maguth, T. ;
Kurila, P. ;
Vasko, L. ;
Racz, O. ;
Nistiar, F. .
ACTA VETERINARIA BRNO, 2008, 77 (02) :175-182
[29]   Chemoprotective potentials of homoisoflavonoids and chalcones of Dracaena cinnabari:: Modulations of drug-metabolizing enzymes and antioxidant activity [J].
Machala, M ;
Kubínová, R ;
Horavová, P ;
Suchy, V .
PHYTOTHERAPY RESEARCH, 2001, 15 (02) :114-118
[30]  
Maezono K, 1996, HEPATOLOGY, V24, P1211